Dietary Protein and the Regulation of Long-Bone and Muscle Growth in the Rat

1994 ◽  
Vol 87 (2) ◽  
pp. 213-224 ◽  
Author(s):  
Z. A. H. Yayha ◽  
D. Joe Millward

1. We report here studies of the interrelationship of bone and muscle growth in the rat and the regulatory role of dietary protein. Two experiments were undertaken. In experiment 1, growth inhibition was induced by ad libitum feeding of low protein diets containing 7%, 3.5% or 0.5% protein, with a control group fed a 20% protein diet. Measurements were made at 1, 3 and 7 days. In experiment 2, complete growth inhibition was induced by ad libitum feeding of a 0.5% protein diet with measurements at 7, 14 and 21 days followed by refeeding diets of 3%, 6%, 9%, 12% and 20% protein, with measurements after 3, 7, 10 and 14 days of refeeding (experimental days 24, 28, 31 and 35). Controls fed a 20% protein diet were studied at 0, 14, 21, 24, 28, 31 and 35 days. 2. Body weight growth stopped immediately in all reduced protein groups, with subsequent weight maintenance on the 7% protein diet, slight loss on the 3.5% protein diet or marked weight loss on the 0.5% protein diet, although food intake was maintained for 3 days, falling in all groups after this time. Inhibition of muscle growth was delayed in the 7% and 3.5% protein fed groups, with 12–15% increases in muscle weight after 7 days, but prompt growth inhibition occurred with the 0.5% protein diet with subsequent weight loss. In animals fed the control 20% protein diet, muscle weight (W) reflected tibial length (L) as W = L3.85/102.93 (r = 0.98, n = 98). Calculation of the muscle weight/bone length ratio (μg/mm3.85) indicated that a significant muscle deficit was apparent on day 3 and subsequently in the 0.5% protein fed rats, but not until day 7 in the 3.5% and 7% protein fed animals. 3. Total tibial length, epiphysis length and epiphyseal cartilage width were measured radiographically. In all groups there was no significant reduction in bone length growth during the first 3 days. After 3 days there were graded reductions on reduced protein intakes with complete inhibition on the 0.5% protein diet. Epiphyseal cartilage width responded sensitively, with a reduction within 24 h of the 0.5% and the 3.5% protein diets, and within 3 days of the 7% protein diet. The epiphysis length was only minimally affected. 4. In experiment 2, food intake increased immediately on refeeding in all except the 3% protein fed group. Accelerated body weight growth occurred in the 20%, 12% and 9% protein fed groups, slower growth in the 6% protein fed and little growth in the 3% protein fed group. Muscle growth commenced immediately in all groups, continuing at an accelerated rate in the 20%, 12% and 9% protein fed groups, at a slower but substantial rate in the 6% fed group and with little further growth in the 3% fed group. This allowed muscle repletion in relation to tibial length (i.e. μg/mm3.85) by day 7 in 9%, 12% and 20% fed protein groups. 5. Bone growth recovered slowly on refeeding, in a graded manner with the protein intakes. Significant increases in tibial length were only observed after 7 days of refeeding with 7–10 days required to fully restore growth in the 20% protein fed group and 10–14 days for the 12% and 9% protein fed groups. Only 50% of the age control rate was achieved in the 6% protein fed group, with little growth in the 3% protein fed group. Although gradual restoration of the epiphyseal cartilage width occurred in a graded manner with increasing protein intakes, complete restoration did not occur in any group. The small reduction in epiphysis length was partially, although not entirely, reversed by refeeding. 6. These studies demonstrate an anabolic drive of dietary protein on bone growth which responds in a graded manner to protein intake at levels in excess of those necessary for maximal rates of muscle growth. Muscle growth appears to be dependent in part on bone length growth, possibly through the anabolic influence of passive muscle stretch.

1994 ◽  
Vol 87 (5) ◽  
pp. 599-606 ◽  
Author(s):  
J. O. Tirapegui ◽  
Z. A. H. Yahya ◽  
P. C. Bates ◽  
D. Joe Millward

1. The influence of dietary energy restriction and corticosterone on long bone and muscle growth, and their interrelationships, was studied in rats fed a range of restricted amounts of diets containing increasing concentrations of protein, thus maintaining constant protein intakes. Tibial length and epiphyseal cartilage width were measured radiographically. 2. In experiment 1, tibial length and gastrocnemius muscle growth were examined in ad libitum fed rats and during 4 days of severe energy restriction (25% ad libitum intake), starvation and ad libitum feeding with corticosterone treatment (10 mg/100 g), a mediator of the response to energy restriction. Weight loss occurred in all groups. Tibial growth continued in the 25% and starvation groups albeit at reduced rates with the inhibition of starvation > 25% group (P < 0.05), but was arrested after 2 days of corticosterone treatment. 3. Muscle growth inhibition was proportional to tibial growth inhibition of the 25% group, insofar as the muscle/bone ratio (W/L3.85), was maintained. This inter-relationship between muscle and bone growth previously reported for ad libitum high-protein-fed rats, is likely to reflect the anabolic influence of bone on muscle via passive muscle stretching induced by length growth. For both starvation and corticosterone groups the muscle/bone ratio fell (P < 0.05 compared with the ad libitum group), suggesting that muscle growth inhibition included an additional direct catabolic influence of starvation and corticosterone treatment. 4. In experiment 2, measurements of bone, muscle and liver growth were made in rats fed 75%, 50% and 25% ad libitum intakes and fed ad libitum intakes with corticosterone treatment for 8 days. Although body weight growth was arrested in all groups with weight loss in the 50%, 25% and corticosterone groups (P < 0.05), some tibial length growth continued at all levels of energy restriction, with significant reductions in length in the 50% and 25% groups at 4 days and in all groups at 8 days. Corticosterone treatment immediately arrested length growth. The epiphyseal cartilage widths of all restricted groups were significantly reduced at 4 days, graded with the degree of restriction, with corticosterone treatment most marked. 5. Muscle growth continued at near normal rates in the 75% and 50% groups, slowing only after 4 days, but was arrested in the corticosterone and 25% group with weight loss by 4 days in the corticosterone group and after 4 days in the 25% group. Muscle growth appeared relatively resistant to direct inhibition by energy restriction, following tibial growth in all restricted groups in that the muscle/bone ratios were initially maintained in all energy-restricted groups, falling only with the corticosterone treatment or 8 days of 50% and 25% intakes. In contrast, liver lost weight in all restricted groups during the first 4 days. 6. The results show a graded delayed inhibitory influence of energy deficiency on bone growth, which may be mediated by corticosteroids given the marked inhibitory influence of corticosterone. The relative resistance of muscle growth to energy restriction during liver and body-weight loss, is consistent with a powerful physiological anabolic stimulus of muscle stretching by bone length growth that appears to override any dietary-induced catabolic influence.


1996 ◽  
Vol 80 (1) ◽  
pp. 208-215 ◽  
Author(s):  
A. X. Bigard ◽  
P. Douce ◽  
D. Merino ◽  
F. Lienhard ◽  
C. Y. Guezennec

Muscle growth, fiber size, muscle and liver glycogen, plasma hormones, and muscle glutamine concentration were evaluated in rats chronically exposed (26 days) to a simulated hypobaric altitude (HA; 6,000 m) and fed diets of varying protein concentrations (10, 20, or 40 g protein/100 g of dry matter; LP, MP, and HP, respectively). Values were compared with those measured in animals maintained under normobaric conditions and either fed ad libitum (SL groups) or pair fed equivalent quantities of food consumed by HA animals (PF groups). There was marked anorexia in response to HA exposure for all protein diets (P < 0.001). A specific effect of hypoxia on the decrease in muscle growth has been identified by comparison of the values of the muscle weight-to-body weight ratio between HA and PF groups (P < 0.05 for all dietary protein levels). Plasma insulin concentrations were lower in HA than in SL and PF rats (P < 0.05). Liver glycogen was significantly decreased by exposure to HA (P < 0.001) and high dietary protein content (P < 0.005). Hypoxia per se and decreased food intake had additive effects on soleus muscle glycogen concentrations. An increase in muscle glutamine was observed in rats fed the LP diet in comparison with the MP diet, especially in SL and PF groups (P < 0.05). These results clearly demonstrate that 1) hypobaric hypoxia per se decreases growth rate in rats and 2) increasing the dietary protein intakes in rat had no effect on the depression of muscle growth related to high altitude but had deleterious effects on glycogen deposition in liver and fast muscle.


1994 ◽  
Vol 87 (5) ◽  
pp. 607-618 ◽  
Author(s):  
Z. A. H. Yahya ◽  
J. O. Tirapegui ◽  
P. C. Bates ◽  
D. Joe Millward

1. We report here the extent to which changes in protein turnover contribute to the previously described inhibition of growth of rat tibial length and skeletal muscle mass in response to protein deficiency [1], energy restriction and corticosterone treatment [2]. Measurements of 35S uptake in vivo also enabled the qualitative pattern of changes in proteoglycan synthesis in bone and muscle to be established. 2. Protein deficiency was examined by ad libitum feeding of 20%, 7%, 3.5% and 0.5% protein diets with measurements at 1, 3 and 7 days (all diets), and 14 and 21 days (0.5% protein). In bone this induced delayed inhibition of tibial growth with parallel inhibition of protein synthesis, as measured by the phenylalanine flooding dose method. This was mediated by reductions in both ribosomal capacity (RNA/protein ratio) and activity (protein synthesis/RNA) in the 0.5% protein group. The pattern of inhibition of proteoglycan sulphation, measured as 35S uptake 60 min after injection of a tracer dose of labelled sulphate, was similar to that of protein synthesis. 3. In muscle there was an intermediate graded inhibition of protein synthesis by protein deficiency, mediated by reductions in both ribosomal capacity and activity in the 0.5% protein group, which preceded growth inhibition in the 7% and 3.5% groups, and which was progressive with time. Transient increases in proteolysis contributed to the growth inhibition is some groups, but the rate fell eventually in the 0.5% group. The pattern of response of proteoglycan sulphation differed from protein synthesis with a delayed inhibition, but with subsequent marked reduction. 4. Energy restriction was induced by diets fed for 4 or 8 days at 75%, 50% and 25% ad libitum intakes with protein intakes held constant, and corticosterone treatment involved a dose of 10 mg day−1 100−1 g (subcutaneous) with ad libitum feeding. In bone this induced a pattern of length growth inhibition which was dissociated from inhibition of protein synthesis in the moderately restricted (75% and 50%) groups. Only in the 25% group and in the 8 day corticosterone group was protein synthesis inhibited, through reductions in ribosomal capacity and activity. 35S uptake was also dissociated from growth inhibition, with reduced 35S uptake observed only after corticosterone treatment or 8 days of the 50% or 25% diets. 5. In muscle the energy restriction and corticosterone treatment induced parallel inhibitions of growth and protein synthesis, mediated by similar graded reductions in the RNA/protein ratios and in the 25% group in the KRNA. Proteolysis was unchanged in all except the 4-day corticosterone group (elevated by 25%) and the day 8 25% group (elevated by 40%) and corticosterone group (elevated by 60%). 35S uptake was inhibited in parallel to muscle growth and protein synthesis. 6. These data show that inhibition of protein synthesis and 35S uptake is an invariable element of muscle growth inhibition, and a usual but not invariable element of bone growth inhibition. Partial correlation analysis of the interactions between dietary protein, bone growth and muscle protein and proteoglycan synthesis shows that bone growth (as indicated by epiphyseal cartilage width) is significantly correlated with muscle protein synthesis and especially 35S uptake, suggesting that the regulation of muscle growth by passive stretch consequent on bone lengthening includes muscle connective tissue growth as an important target.


Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 729
Author(s):  
D Joe Millward

Childhood growth and its sensitivity to dietary protein is reviewed within a Protein-Stat model of growth regulation. The coordination of growth of muscle and stature is a combination of genetic programming, and of two-way mechanical interactions involving the mechanotransduction of muscle growth through stretching by bone length growth, the core Protein-Stat feature, and the strengthening of bone through muscle contraction via the mechanostat. Thus, growth in bone length is the initiating event and this is always observed. Endocrine and cellular mechanisms of growth in stature are reviewed in terms of the growth hormone-insulin like growth factor-1 (GH-IGF-1) and thyroid axes and the sex hormones, which together mediate endochondral ossification in the growth plate and bone lengthening. Cellular mechanisms of muscle growth during development are then reviewed identifying (a) the difficulties posed by the need to maintain its ultrastructure during myofibre hypertrophy within the extracellular matrix and the concept of muscle as concentric “bags” allowing growth to be conceived as bag enlargement and filling, (b) the cellular and molecular mechanisms involved in the mechanotransduction of satellite and mesenchymal stromal cells, to enable both connective tissue remodelling and provision of new myonuclei to aid myofibre hypertrophy and (c) the implications of myofibre hypertrophy for protein turnover within the myonuclear domain. Experimental data from rodent and avian animal models illustrate likely changes in DNA domain size and protein turnover during developmental and stretch-induced muscle growth and between different muscle fibre types. Growth of muscle in male rats during adulthood suggests that “bag enlargement” is achieved mainly through the action of mesenchymal stromal cells. Current understanding of the nutritional regulation of protein deposition in muscle, deriving from experimental studies in animals and human adults, is reviewed, identifying regulation by amino acids, insulin and myofibre volume changes acting to increase both ribosomal capacity and efficiency of muscle protein synthesis via the mechanistic target of rapamycin complex 1 (mTORC1) and the phenomenon of a “bag-full” inhibitory signal has been identified in human skeletal muscle. The final section deals with the nutritional sensitivity of growth of muscle and stature to dietary protein in children. Growth in length/height as a function of dietary protein intake is described in the context of the breastfed child as the normative growth model, and the “Early Protein Hypothesis” linking high protein intakes in infancy to later adiposity. The extensive paediatric studies on serum IGF-1 and child growth are reviewed but their clinical relevance is of limited value for understanding growth regulation; a role in energy metabolism and homeostasis, acting with insulin to mediate adiposity, is probably more important. Information on the influence of dietary protein on muscle mass per se as opposed to lean body mass is limited but suggests that increased protein intake in children is unable to promote muscle growth in excess of that linked to genotypic growth in length/height. One possible exception is milk protein intake, which cohort and cross-cultural studies suggest can increase height and associated muscle growth, although such effects have yet to be demonstrated by randomised controlled trials.


2020 ◽  
Vol 33 (8) ◽  
pp. 1083-1092 ◽  
Author(s):  
Ibrahim Duran ◽  
Kyriakos Martakis ◽  
Christina Stark ◽  
Leonie Schafmeyer ◽  
Mirko Rehberg ◽  
...  

AbstractObjectivesIn children with cerebral palsy (CP), the most common cause of physical impairment in childhood, less muscle and bone growth has been reported, when compared with typically developing children. The aim of this study was to evaluate the effect of an intensive rehabilitation program including physiotherapy in combination with 6 months of home-based, vibration-assisted training on muscle and bone growth in children with CP.MethodsWe included children with CP, who participated in a rehabilitation program utilizing whole-body vibration (WBV). Muscle mass was quantified by appendicular lean mass index (App-LMI) and bone mass by total-body-less-head bone mineral content (TBLH-BMC) assessed by Dual-energy X-ray absorptiometry (DXA) at the beginning of rehabilitation and one year later. To assess the functional muscle-bone unit, the relation of TBLH-BMC to TBLH lean body mass (TBLH-LBM) was used.ResultsThe study population included 128 children (52 females, mean age 11.9 ± 2.7). App-LMI assessed in kg/m2 increased significantly after rehabilitation. The age-adjusted Z-score for App-LMI showed no significant change. TBLH-BMC assessed in gram increased significantly. The Z-scores for TBLH-BMC decreased lesser than expected by the evaluation of the cross-sectional data at the beginning of rehabilitation. The parameter $\frac{TBLH-BMC}{TBLH-LBM}$ did not change relevantly after 12 months.ConclusionsMuscle growth and to a lesser extent bone growth could be increased in children with CP. The intensive rehabilitation program including WBV seemed to have no direct effect on the bone, but the observed anabolic effect on the bone, may only been mediated through the muscle.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Joanna Moro ◽  
Catherine Chaumontet ◽  
Patrick C. Even ◽  
Anne Blais ◽  
Julien Piedcoq ◽  
...  

AbstractTo study, in young growing rats, the consequences of different levels of dietary protein deficiency on food intake, body weight, body composition, and energy balance and to assess the role of FGF21 in the adaptation to a low protein diet. Thirty-six weanling rats were fed diets containing 3%, 5%, 8%, 12%, 15% and 20% protein for three weeks. Body weight, food intake, energy expenditure and metabolic parameters were followed throughout this period. The very low-protein diets (3% and 5%) induced a large decrease in body weight gain and an increase in energy intake relative to body mass. No gain in fat mass was observed because energy expenditure increased in proportion to energy intake. As expected, Fgf21 expression in the liver and plasma FGF21 increased with low-protein diets, but Fgf21 expression in the hypothalamus decreased. Under low protein diets (3% and 5%), the increase in liver Fgf21 and the decrease of Fgf21 in the hypothalamus induced an increase in energy expenditure and the decrease in the satiety signal responsible for hyperphagia. Our results highlight that when dietary protein decreases below 8%, the liver detects the low protein diet and responds by activating synthesis and secretion of FGF21 in order to activate an endocrine signal that induces metabolic adaptation. The hypothalamus, in comparison, responds to protein deficiency when dietary protein decreases below 5%.


Author(s):  
F.E. Van Niekerk ◽  
C.H. Van Niekerk

Sixty-four Thoroughbred and Anglo-Arab mares aged 6-12 years were used, of which 40 were non-lactating and 24 lactating. Foals from these 24 mares were weaned at the age of 6 months. Non-lactating and lactating mares were divided into 4 dietary groups each. The total daily protein intake and the protein quality (essential amino-acid content) differed in the 4 groups of non-lactating and 4 groups of lactating mares. The mares were covered and the effect of the quantity and quality of dietary protein on serum progestagen concentrations during pregnancy was studied. A sharp decline in serum progestagen concentrations was recorded in all dietary groups from Days 18 to 40 of pregnancy, with some individual mares reaching values of less than 4 ng/mℓ. Serum progestagen concentrations recorded in some of the non-lactating mares on the low-quality protein diet increased to higher values (p<0.05) than those of mares in the other 3 dietary groups at 35-140 days of pregnancy. A similar trend was observed for the lactating mares on a low-quality protein diet at 30-84 days of pregnancy. No such trends were observed in any of the other dietary groups. High-quality protein supplementation increased serum progestagen concentrations during the 1st 30 days of pregnancy. Lactation depressed serum progestagen concentrations until after the foals were weaned.


1982 ◽  
Vol 62 (4) ◽  
pp. 1193-1197 ◽  
Author(s):  
P. A. THACKER ◽  
J. P. BOWLAND ◽  
L. P. MILLIGAN ◽  
E. WELTZIEN

The kinetics of urea recycling were determined in six female crossbred pigs utilizing a radioisotope dilution technique. The experimental animals were fed three times daily 500 g of a corn-soybean meal diet formulated to contain 8.4, 15.8 or 24.7% crude protein. Nitrogen digestibility, urinary nitrogen excretion, total nitrogen excretion and retained nitrogen were highest on the 24.7% protein diet and decreased with decreasing dietary protein. Urea pool size, entry rate and excretion rate were also highest on the 24.7% protein diet and decreased with decreasing protein intake. Expressed as a percentage of the total entry rate, a significantly higher percentage of urea was recycled in pigs fed the low protein diets compared with those fed a higher protein diet. Key words: Pig, urea, recycling, kinetics, protein


Endocrinology ◽  
2008 ◽  
Vol 149 (4) ◽  
pp. 1820-1828 ◽  
Author(s):  
Rose Marino ◽  
Anita Hegde ◽  
Kevin M. Barnes ◽  
Lenneke Schrier ◽  
Joyce A. Emons ◽  
...  

Catch-up growth is defined as a linear growth rate greater than expected for age after a period of growth inhibition. We hypothesized that catch-up growth occurs because growth-inhibiting conditions conserve the limited proliferative capacity of growth plate chondrocytes, thus slowing the normal process of growth plate senescence. When the growth-inhibiting condition resolves, the growth plates are less senescent and therefore grow more rapidly than normal for age. To test this hypothesis, we administered propylthiouracil to newborn rats for 8 wk to induce hypothyroidism and then stopped the propylthiouracil to allow catch-up growth. In untreated controls, the growth plates underwent progressive, senescent changes in multiple functional and structural characteristics. We also identified genes that showed large changes in mRNA expression in growth plate and used these changes as molecular markers of senescence. In treated animals, after stopping propylthiouracil, these functional, structural, and molecular senescent changes were delayed, compared with controls. This delayed senescence included a delayed decline in longitudinal growth rate, resulting in catch-up growth. The findings demonstrate that growth inhibition due to hypothyroidism slows the developmental program of growth plate senescence, including the normal decline in the rate of longitudinal bone growth, thus accounting for catch-up growth.


Sign in / Sign up

Export Citation Format

Share Document